Ray Dalio Charles River Laboratories International, Inc. Transaction History

Bridgewater Associates, LP

$21.1 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$203.52 - $273.43 $338,860 - $455,260	-1,665 Reduced 60.22%	1,100 $298,000
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $39,484 - $57,321	-240 Reduced 7.99%	2,765 $653,000
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $252,966 - $283,110	-1,301 Reduced 30.21%	3,005 $588,000
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $206,490 - $236,321	1,124 Added 35.32%	4,306 $905,000
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $50,467 - $68,358	-263 Reduced 7.63%	3,182 $642,000
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $274,377 - $348,097	1,392 Added 67.8%	3,445 $750,000
Q3 2022 Nov 10, 2022	SELL	$182.44 - $250.54 $648,209 - $890,168	-3,553 Reduced 63.38%	2,053 $404,000
Q2 2022 Aug 11, 2022	BUY	$204.13 - $302.4 $135,950 - $201,398	666 Added 13.48%	5,606 $1.2 Million
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $882,276 - $1.25 Million	3,453 Added 232.21%	4,940 $1.4 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $294,456 - $375,993	838 Added 129.12%	1,487 $560,000
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $241,843 - $297,436	649 New	649 $268,000
Q4 2019 Feb 13, 2020	SELL	$126.05 - $152.76 $429,326 - $520,300	-3,406 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$125.07 - $143.67 $425,988 - $489,340	3,406 New	3,406 $451,000
Q1 2019 May 14, 2019	SELL	$104.82 - $146.73 $1.59 Million - $2.23 Million	-15,166 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$105.09 - $137.23 $1.27 Million - $1.66 Million	12,120 Added 397.9%	15,166 $1.72 Million
Q3 2018 Nov 13, 2018	SELL	$112.11 - $134.54 $836,228 - $1 Million	-7,459 Reduced 71.0%	3,046 $410,000
Q2 2018 Aug 13, 2018	SELL	$102.37 - $117.25 $178,123 - $204,015	-1,740 Reduced 14.21%	10,505 $0
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $1.2 Million - $1.41 Million	12,245 New	12,245 $1.31 Million
Q4 2017 Feb 13, 2018	SELL	$100.43 - $118.09 $258,506 - $303,963	-2,574 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $248,957 - $281,235	2,574	2,574 $278,000

Others Institutions Holding CRL

# of Institutions

710

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

Vanguard Group Inc Valley Forge, PA

6.16M
Shares

$1.02 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$841 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

4.08M
Shares

$674 Million
0.14% of portfolio
State Street Corp Boston, MA

2.18M
Shares

$361 Million
0.02% of portfolio
Allspring Global Investments Holdings, LLC

1.81M
Shares

$299 Million
0.56% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.41B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account